Healthy Living/WellnessFDA advisers give thumbs up to MannKind's inhaled insulin drug for diabetics The U.S. FDA panel of advisers okays insulin that can be inhaled rather than injected. This would be the third time that MannKind, its manufacturer, has sought approval from the FDA for its new drug called Afrezza.by Maryanne Moll
Healthy Living/WellnessApple slices or fries? 'Deceptive' fast food advertising confuses childrenby Tabitha Laffernis
Healthy Living/WellnessImmunotherapy makes its way to the U.S. in the form of grass allergy pill Oralairby Tabitha Laffernis
Healthy Living/WellnessWHO says Ebola outbreak in Guinea relatively small. What's to know about the deadly virus?by Rhodi Lee
Healthy Living/WellnessIs Novartis' LCZ696 the next gold standard of heart failure drugs?by Rhodi Lee
Healthy Living/WellnessBenefits of Vitamin D supplements are just part of marketing hype and big myth?by Rhodi Lee
Healthy Living/WellnessDementia diagnosis push in Britain may lead to overdiagnosis: Studyby Maryanne Moll
Healthy Living/WellnessBariatric surgery helps control symptoms of Type 2 diabetes in overweight, obese patientsby Rhodi Lee
Healthy Living/WellnessJapan's Riken Institute admits to falsification in 'game-changing' stem cell studyby Tabitha Laffernis
Healthy Living/WellnessHeart health of young adults linked to brain function in later yearsby Tabitha Laffernis
Healthy Living/WellnessObamacare pulls off the unthinkable, reaches goal of seven million enrolmentsby Tabitha Laffernis
Healthy Living/WellnessSeven portions of fruits and vegetables daily lowers risk of early death by 42 pctby Rhodi Lee
Pete Hegseth Reportedly Shared Details of Yemen Attacks in Another Signal Chat That Has His Wife in It